Búsqueda | Portal de Búsqueda de la BVS Ecuador

1.

The evidence-based role of catecholaminergic PET tracers in Neuroblastoma. A systematic review and a head-to-head comparison with mIBG scintigraphy.

Piccardo, Arnoldo; Treglia, Giorgio; Fiz, Francesco; Bar-Sever, Zvi; Bottoni, Gianluca; Biassoni, Lorenzo; Borgwardt, Lise; de Keizer, Bart; Jehanno, Nina; Lopci, Egesta; Kurch, Lars; Massollo, Michela; Nadel, Helen; Roca Bielsa, Isabel; Shulkin, Barry; Vali, Reza; De Palma, Diego; Cecchin, Diego; Santos, Ana Isabel; Zucchetta, Pietro.

Eur J Nucl Med Mol Imaging ; 51(3): 756-767, 2024 Feb.

Artículo en Inglés | MEDLINE | ID: mdl-37962616

2.

Prostate cancer: nuclear medicine imaging in the biochemical recurrence and in oligometastatic disease.

Muraglia, Lorenzo; Lopci, Egesta; Jandric, Jelena; Zanca, Roberta; Rodari, Marcello; Perrino, Matteo; Lucchini, Raffaella; Baldaccini, Davide; Ceci, Francesco; Evangelista, Laura.

Q J Nucl Med Mol Imaging ; 68(2): 95-100, 2024 Jun.

Artículo en Inglés | MEDLINE | ID: mdl-38860273

3.

Designing clinical trials based on modern imaging and metastasis-directed treatments in patients with oligometastatic breast cancer: a consensus recommendation from the EORTC Imaging and Breast Cancer Groups.

Pasquier, David; Bidaut, Luc; Oprea-Lager, Daniela Elena; deSouza, Nandita M; Krug, David; Collette, Laurence; Kunz, Wolfgang; Belkacemi, Yazid; Bau, Maria Grazia; Caramella, Caroline; De Geus-Oei, Lioe-Fee; De Caluwé, Alex; Deroose, Christophe; Gheysens, Olivier; Herrmann, Ken; Kindts, Isabelle; Kontos, Michalis; Kümmel, Sherko; Linderholm, Barbro; Lopci, Egesta; Meattini, Icro; Smeets, Ann; Kaidar-Person, Orit; Poortmans, Philip; Tsoutsou, Pelagia; Hajjaji, Nawale; Russell, Nicola; Senkus, Elzbieta; Talbot, Jean-Noël; Umutlu, Lale; Vandecaveye, Vincent; Verhoeff, Joost J C; van Oordt, Willemien Menke-van der Houven; Zacho, Helle D; Cardoso, Fatima; Fournier, Laure; Van Duijnhoven, Frederieke; Lecouvet, Frédéric E.

Lancet Oncol ; 24(8): e331-e343, 2023 08.

Artículo en Inglés | MEDLINE | ID: mdl-37541279

4.

Emerging and Evolving Concepts in Cancer Immunotherapy Imaging.

Dercle, Laurent; Sun, Shawn; Seban, Romain-David; Mekki, Ahmed; Sun, Roger; Tselikas, Lambros; Hans, Sophie; Bernard-Tessier, Alice; Mihoubi Bouvier, Fadila; Aide, Nicolas; Vercellino, Laetitia; Rivas, Alexia; Girard, Antoine; Mokrane, Fatima-Zohra; Manson, Guillaume; Houot, Roch; Lopci, Egesta; Yeh, Randy; Ammari, Samy; Schwartz, Lawrence H.

Radiology ; 306(1): 32-46, 2023 01.

Artículo en Inglés | MEDLINE | ID: mdl-36472538

5.

Is PSMA PET/CT cost-effective for the primary staging in prostate cancer? First results for European countries and the USA based on the proPSMA trial.

Holzgreve, Adrien; Unterrainer, Marcus; Calais, Jérémie; Adams, Thaiza; Oprea-Lager, Daniela E; Goffin, Karolien; Lopci, Egesta; Unterrainer, Lena M; Kramer, Kristina K M; Schmidt-Hegemann, Nina-Sophie; Casuscelli, Jozefina; Stief, Christian G; Ricke, Jens; Bartenstein, Peter; Kunz, Wolfgang G; Mehrens, Dirk.

Eur J Nucl Med Mol Imaging ; 50(12): 3750-3754, 2023 10.

Artículo en Inglés | MEDLINE | ID: mdl-37428216

6.

Diagnostic Performance and Clinical Impact of PSMA PET/CT versus mpMRI in Patients with a High Suspicion of Prostate Cancer and Previously Negative Biopsy: A Prospective Trial (PROSPET-BX).

Lopci, Egesta; Lazzeri, Massimo; Colombo, Piergiuseppe; Casale, Paolo; Buffi, Nicolo M; Saita, Alberto; Peschechera, Roberto; Hurle, Rodolfo; Marzo, Katia; Leonardi, Lorenzo; Morenghi, Emanuela; Balzarini, Luca; Disconzi, Luca; Guazzoni, Giorgio; Chiti, Arturo; Lughezzani, Giovanni.

Urol Int ; 107(5): 433-439, 2023.

Artículo en Inglés | MEDLINE | ID: mdl-36724746

7.

Joint EANM/SIOPE/RAPNO practice guidelines/SNMMI procedure standards for imaging of paediatric gliomas using PET with radiolabelled amino acids and [¹⁸F]FDG: version 1.0.

Piccardo, Arnoldo; Albert, Nathalie L; Borgwardt, Lise; Fahey, Frederic H; Hargrave, Darren; Galldiks, Norbert; Jehanno, Nina; Kurch, Lars; Law, Ian; Lim, Ruth; Lopci, Egesta; Marner, Lisbeth; Morana, Giovanni; Young Poussaint, Tina; Seghers, Victor J; Shulkin, Barry L; Warren, Katherine E; Traub-Weidinger, Tatjana; Zucchetta, Pietro.

Eur J Nucl Med Mol Imaging ; 49(11): 3852-3869, 2022 09.

Artículo en Inglés | MEDLINE | ID: mdl-35536420

8.

Interpretation of 2-[¹⁸F]FDG PET/CT in Hodgkin lymphoma patients treated with immune checkpoint inhibitors.

Manson, Guillaume; Lemchukwu, Amaeshi Chukwunonye; Mokrane, Fatima-Zohra; Lopci, Egesta; Aide, Nicolas; Vercellino, Laetitia; Houot, Roch; Dercle, Laurent.

Eur Radiol ; 32(9): 6536-6544, 2022 Sep.

Artículo en Inglés | MEDLINE | ID: mdl-35344061

9.

Incorporating radiomics into clinical trials: expert consensus endorsed by the European Society of Radiology on considerations for data-driven compared to biologically driven quantitative biomarkers.

Fournier, Laure; Costaridou, Lena; Bidaut, Luc; Michoux, Nicolas; Lecouvet, Frederic E; de Geus-Oei, Lioe-Fee; Boellaard, Ronald; Oprea-Lager, Daniela E; Obuchowski, Nancy A; Caroli, Anna; Kunz, Wolfgang G; Oei, Edwin H; O'Connor, James P B; Mayerhoefer, Marius E; Franca, Manuela; Alberich-Bayarri, Angel; Deroose, Christophe M; Loewe, Christian; Manniesing, Rashindra; Caramella, Caroline; Lopci, Egesta; Lassau, Nathalie; Persson, Anders; Achten, Rik; Rosendahl, Karen; Clement, Olivier; Kotter, Elmar; Golay, Xavier; Smits, Marion; Dewey, Marc; Sullivan, Daniel C; van der Lugt, Aad; deSouza, Nandita M.

Eur Radiol ; 31(8): 6001-6012, 2021 Aug.

Artículo en Inglés | MEDLINE | ID: mdl-33492473

10.

Non-FDG PET/CT.

Lopci, Egesta; Fanti, Stefano.

Recent Results Cancer Res ; 216: 669-718, 2020.

Artículo en Inglés | MEDLINE | ID: mdl-32594402

11.

Update on tumor metabolism and patterns of response to immunotherapy.

Castello, Angelo; Lopci, Egesta.

Q J Nucl Med Mol Imaging ; 64(2): 175-185, 2020 Jun.

Artículo en Inglés | MEDLINE | ID: mdl-32107904

12.

Independent expression of circulating and tissue levels of PD-L1: correlation of clusters with tumor metabolism and outcome in patients with non-small cell lung cancer.

Grizzi, Fabio; Castello, Angelo; Qehajaj, Dorina; Toschi, Luca; Rossi, Sabrina; Pistillo, Daniela; Paleari, Valentina; Veronesi, Giulia; Novellis, Pierluigi; Monterisi, Simona; Mineri, Rossana; Rahal, Daoud; Lopci, Egesta.

Cancer Immunol Immunother ; 68(9): 1537-1545, 2019 Sep.

Artículo en Inglés | MEDLINE | ID: mdl-31482306

13.

FDG PET/CT for assessing tumour response to immunotherapy : Report on the EANM symposium on immune modulation and recent review of the literature.

Aide, Nicolas; Hicks, Rodney J; Le Tourneau, Christophe; Lheureux, Stéphanie; Fanti, Stefano; Lopci, Egesta.

Eur J Nucl Med Mol Imaging ; 46(1): 238-250, 2019 01.

Artículo en Inglés | MEDLINE | ID: mdl-30291373

14.

FDG PET in response evaluation of bulky masses in paediatric Hodgkin's lymphoma (HL) patients enrolled in the Italian AIEOP-LH2004 trial.

Lopci, Egesta; Mascarin, Maurizio; Piccardo, Arnoldo; Castello, Angelo; Elia, Caterina; Guerra, Luca; Borsatti, Eugenio; Sala, Alessandra; Todesco, Alessandra; Zucchetta, Pietro; Farruggia, Piero; Cistaro, Angelina; Buffardi, Salvatore; Bertolini, Patrizia; Bianchi, Maurizio; Moleti, Maria Luisa; Bunkheila, Feisal; Indolfi, Paolo; Fagioli, Franca; Garaventa, Alberto; Burnelli, Roberta.

Eur J Nucl Med Mol Imaging ; 46(1): 97-106, 2019 01.

Artículo en Inglés | MEDLINE | ID: mdl-30219963

15.

Joint EANM/EANO/RANO practice guidelines/SNMMI procedure standards for imaging of gliomas using PET with radiolabelled amino acids and [¹⁸F]FDG: version 1.0.

Law, Ian; Albert, Nathalie L; Arbizu, Javier; Boellaard, Ronald; Drzezga, Alexander; Galldiks, Norbert; la Fougère, Christian; Langen, Karl-Josef; Lopci, Egesta; Lowe, Val; McConathy, Jonathan; Quick, Harald H; Sattler, Bernhard; Schuster, David M; Tonn, Jörg-Christian; Weller, Michael.

Eur J Nucl Med Mol Imaging ; 46(3): 540-557, 2019 03.

Artículo en Inglés | MEDLINE | ID: mdl-30519867

16.

Response assessment of bone metastatic disease: seeing the forest for the trees RECIST, PERCIST, iRECIST, and PCWG-2.

Castello, Angelo; Lopci, Egesta.

Q J Nucl Med Mol Imaging ; 63(2): 150-158, 2019 Jun.

Artículo en Inglés | MEDLINE | ID: mdl-31286751

17.

Frameless stereotactic biopsy for precision neurosurgery: diagnostic value, safety, and accuracy.

Sciortino, Tommaso; Fernandes, Bethania; Conti Nibali, Marco; Gay, Lorenzo G; Rossi, Marco; Lopci, Egesta; Colombo, Anna E; Elefante, Maria G; Pessina, Federico; Bello, Lorenzo; Riva, Marco.

Acta Neurochir (Wien) ; 161(5): 967-974, 2019 05.

Artículo en Inglés | MEDLINE | ID: mdl-30895395

18.

Use of modern imaging methods to facilitate trials of metastasis-directed therapy for oligometastatic disease in prostate cancer: a consensus recommendation from the EORTC Imaging Group.

Lecouvet, Frédéric E; Oprea-Lager, Daniela E; Liu, Yan; Ost, Piet; Bidaut, Luc; Collette, Laurence; Deroose, Christophe M; Goffin, Karolien; Herrmann, Ken; Hoekstra, Otto S; Kramer, Gem; Lievens, Yolande; Lopci, Egesta; Pasquier, David; Petersen, Lars J; Talbot, Jean-Noël; Zacho, Helle; Tombal, Bertrand; deSouza, Nandita M.

Lancet Oncol ; 19(10): e534-e545, 2018 10.

Artículo en Inglés | MEDLINE | ID: mdl-30303127

19.

Emerging and Evolving Concepts in Cancer Immunotherapy Imaging.

Dercle, Laurent; Sun, Shawn; Seban, Romain-David; Mekki, Ahmed; Sun, Roger; Tselikas, Lambros; Hans, Sophie; Bernard-Tessier, Alice; Bouvier, Fadila Mihoubi; Aide, Nicolas; Vercellino, Laetitia; Rivas, Alexia; Girard, Antoine; Mokrane, Fatima-Zohra; Manson, Guillaume; Houot, Roch; Lopci, Egesta; Yeh, Randy; Ammari, Samy; Schwartz, Lawrence H.

Radiology ; 306(3): e239003, 2023 Mar.

Artículo en Inglés | MEDLINE | ID: mdl-36803004

20.

⁶⁸Ga-PSMA Positron Emission Tomography/Computerized Tomography for Primary Diagnosis of Prostate Cancer in Men with Contraindications to or Negative Multiparametric Magnetic Resonance Imaging: A Prospective Observational Study.

Lopci, Egesta; Saita, Alberto; Lazzeri, Massimo; Lughezzani, Giovanni; Colombo, Piergiuseppe; Buffi, Nicolò Maria; Hurle, Rodolfo; Marzo, Katia; Peschechera, Roberto; Benetti, Alessio; Zandegiacomo, Silvia; Pasini, Luisa; Lista, Giuliana; Cardone, Pasquale; Castello, Angelo; Maffei, Davide; Balzarini, Luca; Chiti, Arturo; Guazzoni, Giorgio; Casale, Paolo.

J Urol ; 200(1): 95-103, 2018 07.

Artículo en Inglés | MEDLINE | ID: mdl-29409824

Portal de Búsqueda de la BVS Ecuador

Información y Conocimiento para la Salud

Configurar filtros

Su selección (0)

Formato de exportación:

Exportar:

The evidence-based role of catecholaminergic PET tracers in Neuroblastoma. A systematic review and a head-to-head comparison with mIBG scintigraphy.

Prostate cancer: nuclear medicine imaging in the biochemical recurrence and in oligometastatic disease.

Designing clinical trials based on modern imaging and metastasis-directed treatments in patients with oligometastatic breast cancer: a consensus recommendation from the EORTC Imaging and Breast Cancer Groups.

Emerging and Evolving Concepts in Cancer Immunotherapy Imaging.

Is PSMA PET/CT cost-effective for the primary staging in prostate cancer? First results for European countries and the USA based on the proPSMA trial.

Diagnostic Performance and Clinical Impact of PSMA PET/CT versus mpMRI in Patients with a High Suspicion of Prostate Cancer and Previously Negative Biopsy: A Prospective Trial (PROSPET-BX).

Joint EANM/SIOPE/RAPNO practice guidelines/SNMMI procedure standards for imaging of paediatric gliomas using PET with radiolabelled amino acids and [¹⁸F]FDG: version 1.0.

Interpretation of 2-[¹⁸F]FDG PET/CT in Hodgkin lymphoma patients treated with immune checkpoint inhibitors.

Incorporating radiomics into clinical trials: expert consensus endorsed by the European Society of Radiology on considerations for data-driven compared to biologically driven quantitative biomarkers.

Non-FDG PET/CT.

Update on tumor metabolism and patterns of response to immunotherapy.

Independent expression of circulating and tissue levels of PD-L1: correlation of clusters with tumor metabolism and outcome in patients with non-small cell lung cancer.

FDG PET/CT for assessing tumour response to immunotherapy : Report on the EANM symposium on immune modulation and recent review of the literature.

FDG PET in response evaluation of bulky masses in paediatric Hodgkin's lymphoma (HL) patients enrolled in the Italian AIEOP-LH2004 trial.

Joint EANM/EANO/RANO practice guidelines/SNMMI procedure standards for imaging of gliomas using PET with radiolabelled amino acids and [¹⁸F]FDG: version 1.0.

Response assessment of bone metastatic disease: seeing the forest for the trees RECIST, PERCIST, iRECIST, and PCWG-2.

Frameless stereotactic biopsy for precision neurosurgery: diagnostic value, safety, and accuracy.

Use of modern imaging methods to facilitate trials of metastasis-directed therapy for oligometastatic disease in prostate cancer: a consensus recommendation from the EORTC Imaging Group.

Emerging and Evolving Concepts in Cancer Immunotherapy Imaging.

⁶⁸Ga-PSMA Positron Emission Tomography/Computerized Tomography for Primary Diagnosis of Prostate Cancer in Men with Contraindications to or Negative Multiparametric Magnetic Resonance Imaging: A Prospective Observational Study.